Targeting BET bromodomain proteins in solid tumors

There is increasing interest in inhibitors targeting BET (bromodomain and extra-terminal) proteins because of the association between this family of proteins and cancer progression. BET inhibitors were initially shown to have efficacy in hematologic malignancies; however, a number of studies have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahai, Vaibhav, Redig, Amanda J., Collier, Katharine A., Eckerdt, Frank D., Munshi, Hidayatullah G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288238/
https://www.ncbi.nlm.nih.gov/pubmed/27283767
http://dx.doi.org/10.18632/oncotarget.9804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288238/
https://www.ncbi.nlm.nih.gov/pubmed/27283767
http://dx.doi.org/10.18632/oncotarget.9804

Ejemplares similares